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The recent publication of the Joint British Diabetes Societies 
for Inpatient Care (JBDS- IP) guideline, Inpatient Care of the 
Frail Older Adult with Diabetes1 in this journal, represents a 
milestone in how we view modern diabetes care approaches 
to our ageing inpatient population. It also is a timely but de-
layed recognition of frailty as an emerging high impact com-
plication of diabetes.2 The guideline creates an important 
opportunity for diabetes inpatient teams to include frailty in 
their care pathways and in their local curricula of education 
and training for staff.
This Commentary is designed to increase the momentum 
of the JBDS- IP Guideline by reinforcing its key messages and 
providing a basis for including frailty measures in key pro-
cesses of diabetes care such as national audits and other sim-
ilar initiatives. In addition, the emergence of COVID- 19 has 
highlighted the importance of frailty as a prognostic factor 
in older inpatients (with and without diabetes), and this has 
provided a further prompt for this follow- up Commentary.3
The JBDS- IP guideline delivers three important key mes-
sages to those looking after the frail older inpatient with di-
abetes: firstly, while managing acute illness remains the first 
priority of older inpatients with diabetes, there is a necessity to 
provide a focussed assessment of functional status and detec-
tion of frailty to guide further management; secondly, frailty 
can be screened for using rapid and easy- to- learn methods 
that have been well validated in multiple populations of older 
people; finally, that once frailty is detected, other outcome 
measures, such as assessing risk of hypoglycaemia,4 falls 
rate and quality of life need to be routinely included in the 
diabetes care plan along with glycaemic targets. It is likely 
that adopting these procedures will require a culture change 
as well as a degree of upskilling in health professionals man-
aging those older adults with diabetes.
This JBDS- IP inpatient initiative parallels the publication 
of several international guidelines5,6 that emphasise the spe-
cial needs of older people with diabetes and which empha-
sise the importance of functional assessment and detection of 
frailty, and describe interventions to enhance intrinsic capac-
ity and functional ability. The publication of this guideline 
can, therefore, be seen as a natural and necessary develop-
ment to assist clinicians how to manage frailty successfully 
in an inpatient setting without requiring significant additional 
funding for diabetes care.
Frailty is an important predictor of clinical outcomes and 
there is increasing recognition that early detection of frailty 
can help slow functional decline. Despite this, screening for 
frailty remains poor in most health care settings. This may 
partly be due to the fact that there is no agreed operational 
definition of frailty.7 Frailty should be seen as a state of ex-
treme vulnerability to the effects of low- intensity stressors, 
and results from difficulty in maintaining homeostasis due to 
loss of functional reserve. In essence, it represents a multisys-
tem dysregulation and a pre- disability state associated with 
a considerable decline in health and loss of independence. 
Frailty can also be recognised early in its evolution by detect-
ing a pre- frailty state.
The prevalence of frailty varies according to the clinical 
setting studied and scales for measurement used with rates 
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generally higher among hospitalised people (31%– 58% in el-
derly care wards, 69% in nursing residential homes,8 29% in 
primary care settings9 and 10%– 25% in community- dwelling 
people with diabetes aged 60 years and over 10). Scales that 
appear to have high feasibility for use in inpatient settings and 
clinical interpretation include the FRAIL Scale,11 the Survey 
of Health, Ageing and Retirement in Europe Frailty Index 
(SHARE- FI)12 and the Gérontopôle Frailty Screening Tool 
(GFST) 13 while the Clinical Frailty Scale (CFS)14 has a short 
administration time (<30 sec). Irrespective of what scale is 
used, most are relatively easy to apply and measure frailty 
constructs. In UK primary care settings, the eFI (electronic 
Frailty Index15) is employed to detect frailty in those adults 
aged 65 years and over, and is based on the same conceptual 
model as the CFS. This latter assessment tool requires a soft-
ware program linked to a primary care SystmOne system.
We now have evidence that it is possible to intervene in 
older adults with diabetes and frailty using a combination 
of resistance exercise, nutritional education and medical 
optimisation and this can lead to significant functional im-
provements associated with reduced health care costs.16,17 
Introducing such measures in an inpatient setting would be 
challenging but not impossible. The challenges would be to 
establish a program of intervention that can be introduced 
within a short period of time of admission and carried for-
ward into the community after discharge, and the associated 
upskilling of both secondary care and community- based 
health professionals to deliver the interventions. This would 
represent an integrated and complementary approach that 
would have the potential to reduce health care costs, reduce 
length of stay, lower any associated morbidity and mortality, 
and reduce future unnecessary hospital admissions. These 
actions ensure it becomes a shared philosophy of care and 
action designed to improve the likelihood of benefits. Thus, 
the JBDS- IP frailty guidance,1 which is supported by recent 
national and international clinical guidance on managing 
frailty,18,19 should be implemented in parallel with initiatives 
in primary care such as the introduction of six indicators re-
lating to frailty within the Quality Outcomes Framework con-
tract in the United Kingdom.20
No one can deny the immense success of the United 
Kingdom- based National Diabetes Audit (NaDia) in enhanc-
ing the quality of diabetes inpatient care (such as reduced 
rates of medication errors, severe hypoglycaemia and inpa-
tient occurrence of foot ulcers)21 and the recent Getting it 
Right First Time initiative (GIRFT) which aims to improve 
diabetes care and services for all in the United Kingdom by 
making key recommendations in six areas including type 1 
diabetes, procurement and medicines optimisation, and dia-
betic footcare.22 We urge both of these initiatives and similar 
projects elsewhere to consider proactively to introduce frailty 
measures (since the presence of frailty will influence self- 
care and foot care ability, hypoglycaemia incidence, insulin 
usage and error rates, etc) in the future work. This will pro-
vide greater insight into interpreting data relating to older 
people and may assist to develop new pathways of care that 
are aligned with their special characteristics.
As frailty is now recognised as a significant predictor of 
adverse outcomes in older adults admitted to the hospital, it 
is not surprising that the ongoing COVID- 19 pandemic has 
further highlighted the magnitude of this association particu-
larly in those with diabetes.23 Observational data from studies 
in frail older adults affected by COVID- 19 show a dispropor-
tionately higher rates of mortality in frail older adults com-
pared to those who are fit.3 Moreover, assessment of severity 
of frailty has also been used to determine the ceiling of care 
in COVID- 19- affected people.24 As these decisions are gen-
erally made by admitting physicians, it is imperative that 
health care professionals who undertake these assessments 
are appropriately trained.
We feel that further delay in introducing frailty consid-
erations into diabetes care guidance, protocols and audits 
could lead to a state of continuing suboptimal clinical care 
and may even be seen as a lack of equity of care for older 
people within diabetes health care systems. Frailty detection 
and management must now become part of routine diabetes 
care.10,25
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